Nathalie Belmonte has more than 10 years’ experience working in the field of cell therapy in both academic and industrial biotechnology environments. Specifically, she has extensive experience with the development of mesenchymal stem cells, hematopoietic stem cells and T cells in the fields of regenerative medicine and immunotherapy.
Before joining Promethera Biosciences, Nathalie was VP Discovery at TxCell developing Treg cell-based therapy for autoimmune diseases. Nathalie was a scientist in a French academic laboratory (INSERM) dedicated to the development of cell therapies for muscular dystrophy. Prior to this, Nathalie was a scientist at the San Raffaele Hospital at the Telethon Institute for Gene Therapy (TIGET) in Milan, working in the field of hematopoietic stem cells and muscle regeneration. She started her career working in a French academic lab in Nice (CNRS) working on embryonic and adipose tissue-derived stem cells.
Nathalie has a PhD in Cellular and Molecular Biology from the University of Nice Sophia Antipolis.